Participants will learn what juvenile idiopathic arthritis (JIA) is, how to take a history and perform a physical exam, the process of diagnosing JIA, and the different types of JIA and what treatment options may be available.  Finally, participants will have access to resources to help them co-manage JIA patients and understand how to communicate with patient’s families about JIA.

Target Audience

Rheumatologists, researchers, principal investigators, referring physicians, and industry leads.

Learning Objectives

Upon completion of this activity, participants should be able to:

• Identify presenting symptoms and signs of juvenile idiopathic arthritis (JIA)
• Explain different JIA treatment options
• Describe possible complications of JIA
• Identify specialized needs for children with JIA
  
  

Registration Information

Registration is complimentary.

CME and MOC Information

Accreditation Statement

The American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

The ACR designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Health Professionals

Participants may claim hours to receive a Certificate of Participation for an activity designated for AMA PRA Category 1 Credits™.  By completing this activity, you provide the ACR permission to share completion data with the ACCME and the certifying board(s).

MOC Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

By completing this activity, you provide the ACR permission to share completion data with the ACCME and the certifying board(s).

Faculty and Disclosures

ACR Disclosure Statement

It is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners' and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CME activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CME activity.

Nature of Financial Relationships

Faculty participating in an ACR-sponsored activity must disclose to the planning committee and audience all financial relationships with ineligible companies including, but not limited to:

1. Advisor or review panel member
2. Consultant
3. Employee
4. Officer or Board Member
5. Grant/research support
6. Speaker/honoraria includes speakers bureau, symposia, and expert witness
7. Independent contractor
8. Ownership Interest
9. Royalties
10. Intellectual property/patents
11. Stock options or bond holdings in a for-profit corporation or self-directed pension plan
12. Other financial or material support

None: Has no relevant financial relationship(s) with ineligible companies to disclose.

The faculty reported the following disclosures:

Author: Alexis Begezda, MD
- No financial relationships to disclose 

Author: Evan Mulvihill, MD, MPH
- No financial relationships to disclose 

Author: Jessica Nguyen, MD
- No financial relationships to disclose 

Author, Editor: Karen Onel, MD
- No financial relationships to disclose 

Author, Editor: Grayson Schultz, MS
- No financial relationships to disclose

Author, Editor: Susan Shenoi, MBBS, MS, RhMSUS
- Ineligible companies – nature of relationships

Planning Committee/Content Reviewers Disclosures:

Kristine Carandang, PhD, OTR/L
-No financial relationships to disclose 

Esraa Eloseily, MD
-No financial relationships to disclose

Aviya Lanis, MD
-No financial relationships to disclose

Mark Griffiths, MD
-No financial relationships to disclose

Christina Tempesta, MD
-No financial relationships to disclose

Erin Balay-Dustrude, MD
-No financial relationships to disclose

*All of the relevant financial relationships listed for these individuals have been mitigated.